These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Copper(I) Forms a Redox-Stable 1:2 Complex with α-Synuclein N-Terminal Peptide in a Membrane-Like Environment. Dell'Acqua S; Pirota V; Monzani E; Camponeschi F; De Ricco R; Valensin D; Casella L Inorg Chem; 2016 Jun; 55(12):6100-6. PubMed ID: 27259006 [TBL] [Abstract][Full Text] [Related]
5. The N Terminus of α-Synuclein Forms Cu(II)-Bridged Oligomers. Drew SC Chemistry; 2015 May; 21(19):7111-8. PubMed ID: 25757154 [TBL] [Abstract][Full Text] [Related]
6. Bioinorganic Chemistry of Parkinson's Disease: Affinity and Structural Features of Cu(I) Binding to the Full-Length β-Synuclein Protein. Miotto MC; Pavese MD; Quintanar L; Zweckstetter M; Griesinger C; Fernández CO Inorg Chem; 2017 Sep; 56(17):10387-10395. PubMed ID: 28820253 [TBL] [Abstract][Full Text] [Related]
7. Role of N-terminal methionine residues in the redox activity of copper bound to alpha-synuclein. Rodríguez EE; Arcos-López T; Trujano-Ortiz LG; Fernández CO; González FJ; Vela A; Quintanar L J Biol Inorg Chem; 2016 Sep; 21(5-6):691-702. PubMed ID: 27422629 [TBL] [Abstract][Full Text] [Related]
8. Acetylation Rather than H50Q Mutation Impacts the Kinetics of Cu(II) Binding to α-Synuclein. Teng X; Sheveleva A; Tuna F; Willison KR; Ying L Chemphyschem; 2021 Dec; 22(23):2413-2419. PubMed ID: 34617653 [TBL] [Abstract][Full Text] [Related]
9. Site-specific copper-catalyzed oxidation of α-synuclein: tightening the link between metal binding and protein oxidative damage in Parkinson's disease. Miotto MC; Rodriguez EE; Valiente-Gabioud AA; Torres-Monserrat V; Binolfi A; Quintanar L; Zweckstetter M; Griesinger C; Fernández CO Inorg Chem; 2014 May; 53(9):4350-8. PubMed ID: 24725094 [TBL] [Abstract][Full Text] [Related]
10. Acrolein and Copper as Competitive Effectors of α-Synuclein. Falcone E; Ahmed IMM; Oliveri V; Bellia F; Vileno B; El Khoury Y; Hellwig P; Faller P; Vecchio G Chemistry; 2020 Feb; 26(8):1871-1879. PubMed ID: 31804737 [TBL] [Abstract][Full Text] [Related]
11. C-Terminal Tyrosine Residue Modifications Modulate the Protective Phosphorylation of Serine 129 of α-Synuclein in a Yeast Model of Parkinson's Disease. Kleinknecht A; Popova B; Lázaro DF; Pinho R; Valerius O; Outeiro TF; Braus GH PLoS Genet; 2016 Jun; 12(6):e1006098. PubMed ID: 27341336 [TBL] [Abstract][Full Text] [Related]
12. Coordination of copper to the membrane-bound form of α-synuclein. Dudzik CG; Walter ED; Abrams BS; Jurica MS; Millhauser GL Biochemistry; 2013 Jan; 52(1):53-60. PubMed ID: 23252394 [TBL] [Abstract][Full Text] [Related]
13. Membrane insertion exacerbates the α-Synuclein-Cu(II) dopamine oxidase activity: Metallothionein-3 targets and silences all α-synuclein-Cu(II) complexes. Calvo JS; Mulpuri NV; Dao A; Qazi NK; Meloni G Free Radic Biol Med; 2020 Oct; 158():149-161. PubMed ID: 32712192 [TBL] [Abstract][Full Text] [Related]
14. Isomers of human alpha-synuclein stabilized by disulfide bonds exhibit distinct structural and aggregative properties. Jiang C; Chang JY Biochemistry; 2007 Jan; 46(2):602-9. PubMed ID: 17209570 [TBL] [Abstract][Full Text] [Related]
15. Dopamine quinones interact with alpha-synuclein to form unstructured adducts. Bisaglia M; Tosatto L; Munari F; Tessari I; de Laureto PP; Mammi S; Bubacco L Biochem Biophys Res Commun; 2010 Apr; 394(2):424-8. PubMed ID: 20226175 [TBL] [Abstract][Full Text] [Related]
16. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein. Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536 [TBL] [Abstract][Full Text] [Related]
17. Copper(I/II), α/β-Synuclein and Amyloid-β: Menage à Trois? De Ricco R; Valensin D; Dell'Acqua S; Casella L; Hureau C; Faller P Chembiochem; 2015 Nov; 16(16):2319-28. PubMed ID: 26338312 [TBL] [Abstract][Full Text] [Related]
18. Cu Wang H; Mörman C; Sternke-Hoffmann R; Huang CY; Prota A; Ma P; Luo J J Inorg Biochem; 2022 Nov; 236():111945. PubMed ID: 35952593 [TBL] [Abstract][Full Text] [Related]
19. Carboxy-terminal truncation and phosphorylation of α-synuclein elongates survival in a prion-like seeding mouse model of synucleinopathy. Sorrentino ZA; Hass E; Vijayaraghavan N; Gorion KM; Riffe CJ; Dhillon JS; Giasson BI Neurosci Lett; 2020 Jul; 732():135017. PubMed ID: 32371157 [TBL] [Abstract][Full Text] [Related]
20. Pathological role of lipid interaction with α-synuclein in Parkinson's disease. Suzuki M; Sango K; Wada K; Nagai Y Neurochem Int; 2018 Oct; 119():97-106. PubMed ID: 29305919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]